Compare DNUT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNUT | SOPH |
|---|---|---|
| Founded | 1937 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.0M | 462.3M |
| IPO Year | 2021 | 2021 |
| Metric | DNUT | SOPH |
|---|---|---|
| Price | $3.40 | $7.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $4.18 | ★ $9.75 |
| AVG Volume (30 Days) | ★ 2.5M | 535.2K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,522,616,000.00 | N/A |
| Revenue This Year | N/A | $23.24 |
| Revenue Next Year | $4.03 | $24.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.81 | $3.83 |
| 52 Week High | $4.75 | $8.98 |
| Indicator | DNUT | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 68.13 | 44.36 |
| Support Level | $3.26 | $4.58 |
| Resistance Level | $3.72 | $8.80 |
| Average True Range (ATR) | 0.12 | 0.47 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 85.00 | 44.75 |
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.